{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:32:32Z","timestamp":1777635152522,"version":"3.51.4"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/ico.0b013e3181e458c5","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T11:25:49Z","timestamp":1284636349000},"page":"60-66","source":"Crossref","is-referenced-by-count":33,"title":["Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition"],"prefix":"10.1097","volume":"30","author":[{"given":"Hsiao-Sang","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fung-Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-May","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ting","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bjo.72.5.338","article-title":"Idiopathic bilateral lipid keratopathy.","volume":"72","author":"Alfonso","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.18.4.519","article-title":"Lipid keratopathy and atheroma.","volume":"18","author":"Cogan","year":"1958","journal-title":"Circulation"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0161-6420(85)34092-7","article-title":"Bilateral and massive lipoidal infiltration of the cornea (secondary lipoidal degeneration).","volume":"92","author":"Croxatto","year":"1985","journal-title":"Ophthalmology"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archopht.1977.04450030098013","article-title":"Lipid keratopathy following corneal hydrops.","volume":"95","author":"Shapiro","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1600-0420.2003.00025.x","article-title":"Bilateral centripetal lipid keratopathy with diffuse anterior scleritis.","volume":"81","author":"Morisawa","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/emboj\/19.7.1525","article-title":"Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.","volume":"19","author":"Binetruy-Tournaire","year":"2000","journal-title":"EMBO J"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing.","volume":"82","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"R9-12-20210204","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1091\/mbc.3.2.211","article-title":"Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.","volume":"3","author":"Berse","year":"1992","journal-title":"Mol Biol Cell"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000267567","article-title":"Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.","volume":"27","author":"Murata","year":"1995","journal-title":"Ophthalmic Res"},{"key":"R12-12-20210204","first-page":"2729","article-title":"Vascular endothelial growth factor (VEGF) and vascular permeability change in human diabetic retinopathy.","volume":"38","author":"Kunz Mathews","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.","volume":"103","author":"Tolentino","year":"1996","journal-title":"Ophthalmology"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Subconjunctival bevacizumab for vascularized rejected corneal grafts.","volume":"33","author":"Awadein","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S0001-37652007000300004","article-title":"The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea.","volume":"79","author":"Barros","year":"2007","journal-title":"An Acad Bras Cienc"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":"Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.ico.0000611440.32234.8f","article-title":"Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.","volume":"27","author":"Carrasco","year":"2008","journal-title":"Cornea"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of Bevacizumab (Avastin) inhibits corneal neovascularization in different rabbit models of corneal angiogenesis.","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.125.6.834","article-title":"Topical bevacizumab therapy for corneal neovascularization.","volume":"125","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","article-title":"Subconjunctival bevacizumab for corneal neovascularization.","volume":"245","author":"Erdurmus","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0b013e31819839f9","article-title":"Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.","volume":"28","author":"Oh","year":"2009","journal-title":"Cornea"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0886-3350(00)00371-0","article-title":"Surgical results of photorefractive keratectomy with different operative modes.","volume":"26","author":"Chen","year":"2000","journal-title":"J Cataract Refract Surg"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-6257(91)90205-T","article-title":"The cornea and disorders of lipid metabolism.","volume":"36","author":"Barchiesi","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"R26-12-20210204","first-page":"221","article-title":"The permeability of the capillary wall to the different plasma lipoproteins of the hypercholesterolaemic rabbit in the relation to their size.","volume":"47","author":"Courtice","year":"1962","journal-title":"Q J Exp Physiol Cogn Med Sci"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/path.1711110407","article-title":"Studies on the pathogenesis of corneal arcus formation. I. The human corneal arcus and its relation to atherosclerosis as studied by immunofluorescence.","volume":"111","author":"Walton","year":"1973","journal-title":"J Pathol"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1711140406","article-title":"Studies on the pathogenesis of corneal arcus formation II. Immunofluorescent studies on lipid deposition in the eye of the lipid-fed rabbit.","volume":"114","author":"Walton","year":"1974","journal-title":"J Pathol"},{"key":"R29-12-20210204","first-page":"363","article-title":"Excess lipid leakage: a property of very young vascular endothelium.","volume":"43","author":"Friedman","year":"1962","journal-title":"Br J Exp Pathol"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1350-9462(02)00004-6","article-title":"Ocular lipid deposition and hyperlipoproteinaemia.","volume":"21","author":"Crispin","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R31-12-20210204","first-page":"1588","article-title":"Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat.","volume":"30","author":"Haynes","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","article-title":"Suppression of corneal neovascularization with cyclosporine.","volume":"110","author":"Lipman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004170050330","article-title":"Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency.","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R34-12-20210204","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/jop.1994.10.273","article-title":"Effect of low molecular weight heparan sulphate on angiogenesis in the rat cornea after chemical cauterization.","volume":"10","author":"Lepri","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"R35-12-20210204","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1167\/iovs.05-1425","article-title":"Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.","volume":"47","author":"Shi","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R36-12-20210204","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/bjo.66.2.127","article-title":"Treatment of lipid keratopathy with the argon laser.","volume":"66","author":"Marsh","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"R37-12-20210204","first-page":"154","article-title":"Lasering of lipid keratopathy.","volume":"102","author":"Marsh","year":"1982","journal-title":"Trans Ophthalmol Soc U K"},{"key":"R38-12-20210204","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0161-6420(85)33819-8","article-title":"Clinical applications of the organic dye laser.","volume":"92","author":"LEsperance","year":"1985","journal-title":"Ophthalmology"},{"key":"R39-12-20210204","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R40-12-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"R41-12-20210204","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0b013e3282fb7fb0","article-title":"The treatment of branch retinal vein occlusion with bevacizumab.","volume":"19","author":"Badala","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"R42-12-20210204","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Anti-vascular endothelial growth factor therapy for ocular neovascular disease.","volume":"18","author":"Andreoli","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R43-12-20210204","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1442-9071.2007.01521.x","article-title":"Bevacizumab (Avastin) for the treatment of neovascular glaucoma.","volume":"35","author":"Chilov","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"R44-12-20210204","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta 1 in human corneas with neovascularization.","volume":"19","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"key":"R45-12-20210204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.","volume":"70","author":"Kvanta","year":"2000","journal-title":"Exp Eye Res"},{"key":"R46-12-20210204","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R47-12-20210204","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1442-9071.2007.01572.x","article-title":"Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.","volume":"35","author":"Hosseini","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"R48-12-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":"Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation.","volume":"87","author":"Cursiefen","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R49-12-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization.","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3181e458c5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:32:29Z","timestamp":1621884749000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201101000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181e458c5","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}